Literature DB >> 29341025

Multiple sclerosis: Prevalence and impact.

Heather Gilmour1, Pamela L Ramage-Morin1, Suzy L Wong2.   

Abstract

This article provides new information about multiple sclerosis (MS) using the 2010/2011 Neurological Conditions Prevalence File, the 2011/2012 Survey of Neurological Conditions in Institutions in Canada, and the 2011 Survey on Living with Neurological Conditions in Canada. An estimated 93,500 Canadians living in private households and 3,800 residents of long-term care institutions had been diagnosed with MS. Prevalence estimates were 159 and 418 cases per 100,000 population for men and women, respectively; 2.6 women reported MS for every man with the condition. Among the household population, MS was generally diagnosed between the ages of 20 and 49 (82%). For the majority (68%), MS was their only neurological condition. The impact of MS included pain that prevented activities, impairments in mobility, cognition or sleep, and limitations in social functioning. Almost two-thirds (64%) stated that MS affected their lives at least moderately.

Entities:  

Keywords:  Cognition; mortality; myelitis; neurological disease

Mesh:

Year:  2018        PMID: 29341025

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  12 in total

1.  Exploring Self-management Needs of Persons With Multiple Sclerosis: A Qualitative Study for Mobile Application Development.

Authors:  Shahla Damanabi; Zeinab Salimzadeh; Leila R Kalankesh; Sheida Shaafi; Reza Ferdousi
Journal:  Int J MS Care       Date:  2021-04-16

2.  Physical activity and vascular comorbidity in Black and White persons with multiple sclerosis: A cross-sectional study.

Authors:  Trinh Huynh; Brenda Jeng; Robert W Motl
Journal:  Disabil Health J       Date:  2022-03-08       Impact factor: 4.615

Review 3.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

4.  Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study.

Authors:  Niklas Frahm; Michael Hecker; Uwe Klaus Zettl
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

5.  Systematic review protocol for facilitators and barriers to integrating health services for traumatic brain injury and mental health or addictions.

Authors:  Vincy Chan; Danielle Toccalino; Angela Colantonio
Journal:  BMJ Open       Date:  2019-07-23       Impact factor: 2.692

6.  Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.

Authors:  C Blaney; J Sommer; R El-Gabalawy; C Bernstein; R Walld; C Hitchon; J Bolton; J Sareen; S Patten; A Singer; L Lix; A Katz; J Fisk; R A Marrie
Journal:  Epidemiol Psychiatr Sci       Date:  2020-01-09       Impact factor: 6.892

Review 7.  Viral infections and their relationship to neurological disorders.

Authors:  Jéssica Wouk; Daniele Zendrini Rechenchoski; Bianca Cerqueira Dias Rodrigues; Elisa Vicente Ribelato; Ligia Carla Faccin-Galhardi
Journal:  Arch Virol       Date:  2021-01-27       Impact factor: 2.574

Review 8.  The Canadian Women's Heart Health Alliance ATLAS on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 2: Scope of the Problem.

Authors:  Shahin Jaffer; Heather J A Foulds; Monica Parry; Christine A Gonsalves; Christine Pacheco; Marie-Annick Clavel; Kerri A Mullen; Cindy Y Y Yip; Sharon L Mulvagh; Colleen M Norris
Journal:  CJC Open       Date:  2020-10-15

Review 9.  Potential Role of Ginger (Zingiber officinale Roscoe) in the Prevention of Neurodegenerative Diseases.

Authors:  Raúl Arcusa; Débora Villaño; Javier Marhuenda; Miguel Cano; Begoña Cerdà; Pilar Zafrilla
Journal:  Front Nutr       Date:  2022-03-18

10.  Is it worth it?: The experiences of persons with multiple sclerosis as they access health care to manage their condition.

Authors:  Julie Pétrin; Catherine Donnelly; Mary-Ann McColl; Marcia Finlayson
Journal:  Health Expect       Date:  2020-07-22       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.